CN101129820A - 一种内服治疗神经衰弱的中药组合物 - Google Patents
一种内服治疗神经衰弱的中药组合物 Download PDFInfo
- Publication number
- CN101129820A CN101129820A CNA2007100165574A CN200710016557A CN101129820A CN 101129820 A CN101129820 A CN 101129820A CN A2007100165574 A CNA2007100165574 A CN A2007100165574A CN 200710016557 A CN200710016557 A CN 200710016557A CN 101129820 A CN101129820 A CN 101129820A
- Authority
- CN
- China
- Prior art keywords
- grams
- fructus
- chinese medicine
- medicine composition
- orally taken
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 title claims description 19
- 206010003549 asthenia Diseases 0.000 title description 9
- 208000007443 Neurasthenia Diseases 0.000 title description 7
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 206010016256 fatigue Diseases 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 240000006766 Cornus mas Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 235000021307 Triticum Nutrition 0.000 abstract 1
- 244000098338 Triticum aestivum Species 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 208000018299 prostration Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 208000008454 Hyperhidrosis Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 230000007958 sleep Effects 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001671 psychotherapy Methods 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 206010029412 Nightmare Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010057315 Daydreaming Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 229960002336 estazolam Drugs 0.000 description 2
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000037315 hyperhidrosis Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010002869 Anxiety symptoms Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010054089 Depressive symptom Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- DIWRORZWFLOCLC-UHFFFAOYSA-N Lorazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- ROYOYTLGDLIGBX-UHFFFAOYSA-N fludiazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1F ROYOYTLGDLIGBX-UHFFFAOYSA-N 0.000 description 1
- 229960004930 fludiazepam Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229960003386 triazolam Drugs 0.000 description 1
- JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种内服治疗神经衰弱的中药组合物,属中药领域。该种内服治疗神经衰弱的中药组合物,制成其有效成分的原料药按下述重量为:天麻20克、枸杞子15克、浮小麦30克、酸枣仁15克、生地15克、夜交藤15克、甘草10克、丹皮10克、山萸肉10克、白芍10克、炒栀子5克、五味子10克。每日1剂,水煎2次调匀,早晚分服,连服15天为1疗程。本发明具有滋补肝肾、补益精血、宁心安神的功效,对头痛、失眠所表现的各种临床症状有较好的治疗效果。
Description
技术领域
本发明涉及一种内服治疗神经衰弱的中药组合物,属中药领域。
背景技术
神经衰弱是以神经过程易于兴奋和易于疲劳为特点,伴随有情绪不稳定、睡眠障碍及植物神经功能紊乱等症状特征的神经症。由于至今国内、外学术界对其定义和判断存在分歧。因此,一个人即使有以上的症状和特点,也不要轻易给自己下神经衰弱的结论,必须请内行的心理医生诊断。
一般认为,神经衰弱多由持续性的紧张情绪刺激所引起,主要表现为疲劳、头痛、腰痛、忧郁、失眠、食欲不振、记忆力减退、注意力不集中等。神经衰弱的病因也较复杂,主要有:①工作过于紧张,长期睡眠不好,人际关系紧张,对工作不满意或婚姻不合谐等。凡是能矛盾冲突的因素都是能导致此病发生的重要原因。②人格因素方面的原因,例如孤僻、内向、敏感、多疑、执拗、患得患失等,都易发生此病。
对神经衰弱的治疗,一般是心理治疗和药物治疗同时进行,其中心理治疗可采用支持性心理治疗和精神放松疗法;药物治疗主要是对症治疗:对焦虑症状和兴奋、易激惹者可先用安定、佳静安定、舒乐安定;失眠严重者可予以氟安定,氯羟安定、三唑仑或催眠药;抑郁症状可选用小剂量三环类抗抑郁药。亦可在辩证论治的基础上选用中药方剂或中成药治疗。但是西药的副作用比较大,容易形成成瘾性耐药性,故不宜长时间应用。
发明内容
本发明的目的在于克服现有治疗的不足,而提供一种内服治疗神经衰弱的中药组合物,全部选用天然中草药,配以适当的心理疗法能够有效治疗神经衰弱。
本发明的技术方案是:该种内服治疗神经衰弱的中药组合物,其特征在于,制成有效成分的原料药按下述重量为:天麻20克、枸杞子15克、浮小麦30克、酸枣仁15克、生地15克、夜交藤15克、甘草10克、丹皮10克、山萸肉10克、白芍10克、炒栀子5克、五味子10克。
每日1剂,水煎2次调匀,早晚分服,连服15天为1疗程。
药理作用:
天麻:平肝息风止痉。用于头痛眩晕,肢体麻木,小儿惊风,癫痫抽搐,破伤风。
枸杞子:滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。
浮小麦:甘,凉。止虚汗,养心安神。用于体虚多汗,脏躁症。
酸枣仁:有养肝、宁心安神、敛汗等功效。
生地:清热凉血,用于血热毒盛,吐血衄血,斑疹紫黑,养阴生津,内热消渴。
夜交藤:入心、肝经。养心,安神,通络,祛风。治失眠,劳伤,多汗,血虚身痛,痈疽,瘰疬,风疮疥癣。
甘草:和中缓急,润肺,解毒,调和诸药。治脾胃虚弱,食少,腹痛便溏,劳倦发热,肺痿咳嗽,心悸,惊厥。
丹皮:性寒,味苦、辛。清热凉血,活血行瘀。用于温毒发斑、吐、衄、便血,骨蒸劳热,经闭痛经,痈肿疮毒,跌扑伤痛。
山萸肉:酸、涩、微温。补益肝肾,涩精止汗:用于肝肾不足之腰酸遗精、头晕目眩、月经过多以及尿频、自汗等症。
白芍:养血柔肝,缓中止痛,敛阴收汗。治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下。
炒栀子:苦,寒。归心、肺、三焦经。泻火除烦,清热利尿,凉血解毒。用于热病心烦,黄疸尿赤,血淋涩痛,血热吐衄,目赤肿痛,火毒疮疡。
五味子:敛肺滋肾,生津敛汗,涩精止血,宁心安神。治肺虚久咳,肺肾虚咳,自汗,盗汗,消渴,梦遗,滑精,久泻不止,心悸,失眠。
本发明具有滋补肝肾、补益精血、宁心安神的功效,对头痛、失眠所表现的各种临床症状有较好的治疗效果。该种内服治疗神经衰弱的中药组合物具有组方合理、释药迅速的优点,能够快速达到缓解症状和治疗神经衰弱的目的。
典型病例:
病例一:高某,男,22岁,在校大学生,学习压力较大。偶尔会有睡眠不好,不能用脑、一用脑就出现头痛、头晕的症状。临近考试,学习更紧张,这些症状进而加重,学习也有所下降,并且注意力不集中、记忆力明显下降,学习效率也很低,看半天书根本不知道书的内容是什么,心里很是着急。去医院诊断为神经衰弱,服用该种内服治疗神经衰弱的中药组合物一个星期后,睡眠好了,头痛、头晕的症状明显改善。治疗期间经常与心里老师沟通。继续服用一个疗程后症状完全消失。现在病人学习很稳定。
病例二:刘某,女,29岁,由于工作紧张、繁杂,自2001年7月份开始出现失眠、多梦,主要是入睡困难。以前她一般每晚九点睡觉,可患病后到十点、甚至十二点钟也不能入睡。上床后,又想起白天工作中的事情,忧虑重重,辗转反侧难以入眠。睡眠浅而且恶梦不断,甚至常有梦魇,突然醒来,大汗淋漓,极端恐惧,到了清晨则毫无清醒感。她为治病去过几家大医院,经诊断为神经衰弱,用过许多西药、点滴等治疗方法,效果不大。抱着试试看的想法,服用该种内服治疗神经衰弱的中药组合物,服药半个疗程后,症状减轻,恶梦减少了,但入睡仍然困难。继续服用治疗两个疗程后,每晚能睡6-7个小时,梦也少了,白天工作明显有精力,食欲也较前好多了。建议她继续服一个疗程巩固,现在已经彻底治愈。
病例三:周某,男,19岁,2006年由于高考时用脑过度经常出现入睡困难易醒、醒后不能再睡、心烦易怒、胸闷气短、精力不足等。在本地某大医院诊断为神经衰弱。服刺五加、谷维素、舒乐安定、维生素B1等药物治疗不见好转。后经人介绍服用该种内服治疗神经衰弱的中药组合物一周病情减轻,又服药三周后病情痊愈,随访至今未复发。
具体实施方式
例一:一种内服治疗神经衰弱的中药组合物,制成有效成分的原料药按下述重量为:天麻20克、枸杞子15克、浮小麦30克、酸枣仁15克、生地15克、夜交藤15克、甘草10克、丹皮10克、山萸肉10克、白芍10克、炒栀子5克、五味子10克。
每日1剂,水煎2次调匀,早晚分服,连服15天为1疗程。
Claims (1)
1.一种内服治疗神经衰弱的中药组合物,其特征在于,制成有效成分的原料药按下述重量为:天麻20克、枸杞子15克、浮小麦30克、酸枣仁15克、生地15克、夜交藤15克、甘草10克、丹皮10克、山萸肉10克、白芍10克、炒栀子5克、五味子10克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100165574A CN100546630C (zh) | 2007-08-23 | 2007-08-23 | 一种内服治疗神经衰弱的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100165574A CN100546630C (zh) | 2007-08-23 | 2007-08-23 | 一种内服治疗神经衰弱的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101129820A true CN101129820A (zh) | 2008-02-27 |
| CN100546630C CN100546630C (zh) | 2009-10-07 |
Family
ID=39127332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007100165574A Expired - Fee Related CN100546630C (zh) | 2007-08-23 | 2007-08-23 | 一种内服治疗神经衰弱的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100546630C (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102008637A (zh) * | 2010-12-09 | 2011-04-13 | 上海市精神卫生中心 | 一种治疗心病型神经衰弱症的合剂及其应用 |
| CN102008638A (zh) * | 2010-12-09 | 2011-04-13 | 上海市精神卫生中心 | 一种治疗心病型神经衰弱的药物 |
| CN104491497A (zh) * | 2015-01-16 | 2015-04-08 | 王艳芬 | 一种治疗神经衰弱的中药组合物 |
| CN104887939A (zh) * | 2015-06-29 | 2015-09-09 | 青岛辰达生物科技有限公司 | 一种治疗神经衰弱的中药制剂及其制备方法 |
| CN106244372A (zh) * | 2016-08-05 | 2016-12-21 | 贵州省中国科学院天然产物化学重点实验室 | 一种改善睡眠的酵素化天麻养生饮品及制备工艺及应用 |
| CN112057542A (zh) * | 2020-08-24 | 2020-12-11 | 河北平安健康集团股份有限公司 | 一种治疗失眠、焦虑、抑郁和更年期综合征的中药组合物及其制备方法 |
| CN118286356A (zh) * | 2024-03-05 | 2024-07-05 | 李京波 | 一种治疗头痛的中药组合物及其应用 |
-
2007
- 2007-08-23 CN CNB2007100165574A patent/CN100546630C/zh not_active Expired - Fee Related
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102008637A (zh) * | 2010-12-09 | 2011-04-13 | 上海市精神卫生中心 | 一种治疗心病型神经衰弱症的合剂及其应用 |
| CN102008638A (zh) * | 2010-12-09 | 2011-04-13 | 上海市精神卫生中心 | 一种治疗心病型神经衰弱的药物 |
| CN104491497A (zh) * | 2015-01-16 | 2015-04-08 | 王艳芬 | 一种治疗神经衰弱的中药组合物 |
| CN104887939A (zh) * | 2015-06-29 | 2015-09-09 | 青岛辰达生物科技有限公司 | 一种治疗神经衰弱的中药制剂及其制备方法 |
| CN106244372A (zh) * | 2016-08-05 | 2016-12-21 | 贵州省中国科学院天然产物化学重点实验室 | 一种改善睡眠的酵素化天麻养生饮品及制备工艺及应用 |
| CN106244372B (zh) * | 2016-08-05 | 2020-06-02 | 贵州省中国科学院天然产物化学重点实验室 | 一种改善睡眠的酵素化天麻养生饮品及制备工艺及应用 |
| CN112057542A (zh) * | 2020-08-24 | 2020-12-11 | 河北平安健康集团股份有限公司 | 一种治疗失眠、焦虑、抑郁和更年期综合征的中药组合物及其制备方法 |
| CN112057542B (zh) * | 2020-08-24 | 2022-05-10 | 河北平安健康集团股份有限公司 | 一种治疗失眠、焦虑、抑郁和更年期综合征的中药组合物及其制备方法 |
| CN114796380A (zh) * | 2020-08-24 | 2022-07-29 | 河北平安健康集团股份有限公司 | 中药组合物在制备用于治疗焦虑的药物中的应用 |
| CN114796380B (zh) * | 2020-08-24 | 2023-07-21 | 河北平安健康集团股份有限公司 | 中药组合物在制备用于治疗焦虑的药物中的应用 |
| CN118286356A (zh) * | 2024-03-05 | 2024-07-05 | 李京波 | 一种治疗头痛的中药组合物及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100546630C (zh) | 2009-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102283999B (zh) | 一种治疗失眠的中药制剂 | |
| CN103251867A (zh) | 一种治疗糖尿病的中药复方药物及其制备方法 | |
| CN100546630C (zh) | 一种内服治疗神经衰弱的中药组合物 | |
| CN102335330B (zh) | 一种治疗失眠的中药组合物 | |
| CN101700336B (zh) | 一种治疗颅脑外伤后遗性头痛的中药制剂及其制备方法 | |
| CN103394058B (zh) | 一种治疗产后风的药物及其制备方法 | |
| CN106266999A (zh) | 一种治疗心神不安及心悸失眠的中药组合物及其制备方法 | |
| CN104971204A (zh) | 一种配合针灸治疗神经性耳鸣的补肾开窍丸及药条 | |
| CN104547598A (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
| CN104043031A (zh) | 一种治疗抑郁症的中药 | |
| CN103736001B (zh) | 一种治疗失眠的中药组合物 | |
| CN104906394A (zh) | 一种治疗肝肾阴虚兼气血亏虚型高血压的中药 | |
| CN103520412A (zh) | 一种治疗美尼尔氏眩晕症的中药汤剂 | |
| CN116350704B (zh) | 一种治疗继发性癫痫的中药组合物及其制备方法 | |
| CN104027784A (zh) | 一种治疗失眠的足浴袋中药组合物 | |
| CN103705733A (zh) | 一种治疗心律不齐的中药胶囊及其制备方法 | |
| CN103961578A (zh) | 一种治疗神经衰弱的中药药酒 | |
| CN102626503B (zh) | 一种舒心益智的中药口服液 | |
| CN107115410B (zh) | 一种中药泡浴配方、制备方法及使用方法 | |
| CN105435083A (zh) | 一种用于产后抑郁症的胶囊剂 | |
| CN105194442A (zh) | 一种用于治疗神经衰弱的中药组合物及其制备方法 | |
| CN106421113A (zh) | 一种用于预防、外治失眠的中药组合物及使用方法 | |
| CN106215133A (zh) | 一种可有效治疗颈椎病的中药组合物及其制备方法 | |
| CN105662037A (zh) | 一种治疗慢性疲劳综合症的枕头及其制备方法 | |
| CN104706961A (zh) | 失眠多梦患者润肺清心中药药剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091007 Termination date: 20100823 |